Japan, Aug. 18 -- ALNYLAM PHARMACEUTICALS INC has got intellectual property rights for 'ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF.' Other related details are as follows:
Application Number: JP,2024-173068
Category (FI): C12N15/113@Z,A61K31/713,A61K35/76,A61K48/00,A61K47/12,A61K47/02,A61K47/42,A61K9/08,A61P43/00,111,A61P43/00,105,A61P15/00,A61P25/00,A61P3/10,A61P5/14,A61P5/18,A61P5/38,A61P35/00,A61P27/02,A61P9/00,A61P9/04,A61P13/12,A61P9/10,A61P11/00,A61P27/06,A61P9/12,A61P9/10,101,A61K45/00,A61K47/54,C12N15/63@Z,C12N1/15,C12N1/19,C12N1/21,C12N5/10
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 2, 2024
Publication Date: Feb. 12, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
